期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
妊娠期糖尿病患者血清Ficolin-3、Omentin-1、FGF19 水平检测及其对发生GDM的预测价值 被引量:1
1
作者 丁雪华 朱玉花 《检验医学与临床》 CAS 2024年第2期242-246,共5页
目的探讨妊娠期糖尿病(GDM)患者血清纤维凝胶蛋白-3(Ficolin-3)、网膜素-1(Omentin-1)、成纤维细胞生长因子19(FGF19)水平检测及意义,以期为临床早期制订干预方案、降低GDM发生率提供参考。方法选取2020年9月至2022年9月于该院孕24~28... 目的探讨妊娠期糖尿病(GDM)患者血清纤维凝胶蛋白-3(Ficolin-3)、网膜素-1(Omentin-1)、成纤维细胞生长因子19(FGF19)水平检测及意义,以期为临床早期制订干预方案、降低GDM发生率提供参考。方法选取2020年9月至2022年9月于该院孕24~28周行口服葡萄糖耐量试验且结果为阳性的96例孕妇作为GDM组,同期96例孕24~28周行口服葡萄糖耐量试验且结果为阴性孕妇作为对照组。比较两组孕11~13周(孕早期)一般资料及检测指标[年龄、体质量指数(BMI)、孕次、产次、孕周、收缩压(SBP)、舒张压(DBP)、空腹血糖(FBG)、糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)];比较两组孕早期血清Ficolin-3、Omentin-1、FGF19水平;采用Pearson相关分析孕早期血清Ficolin-3、Omentin-1、FGF19水平与BMI、FBG、HbA1c、TC、TG、LDL-C水平的相关性;采用受试者工作特征(ROC)曲线分析孕早期血清Ficolin-3、Omentin-1、FGF19联合检测对孕早期发生GDM的预测价值。结果孕早期GDM组BMI、FBG、HbA1c、TC、TG、LDL-C水平均高于对照组,差异均有统计学意义(P<0.05)。孕早期GDM组血清Ficolin-3水平高于对照组,Omentin-1、FGF19水平均低于对照组,差异均有统计学意义(P<0.05)。孕早期血清Ficolin-3水平与BMI、FBG、HbA1c、TC、TG、LDL-C水平均呈正相关(P<0.05);血清Omentin-1、FGF19水平与BMI、FBG、HbA1c、TC、TG、LDL-C水平均呈负相关(P<0.05)。孕早期血清Ficolin-3水平升高及血清Omentin-1、FGF19水平降低为孕早期发生GDM的危险因素(P<0.05)。孕早期血清Ficolin-3、Omentin-1、FGF19联合检测预测发生GDM的曲线下面积为0.930,灵敏度、特异度分别为89.58%、81.25%。结论血清Ficolin-3、Omentin-1、FGF19与GDM的发生具有明显相关性,可为临床早期预测GDM提供参考依据,以便针对性给予干预措施,降低GDM的发生风险,改善母婴结局。 展开更多
关键词 妊娠期糖尿病 纤维凝胶蛋白-3 网膜素-1 成纤维细胞生长因子19 干预方案
下载PDF
厄贝沙坦对糖尿病大鼠肾脏FN、DKK1及β-catenin表达的影响 被引量:2
2
作者 陈碧珊 吴红卫 +2 位作者 李艳 张滨 陈吉生 《山东医药》 CAS 2018年第32期47-50,共4页
目的探讨厄贝沙坦对糖尿病肾损伤的治疗作用及其机制。方法取SD大鼠32只,随机选取10只设为正常组,余22只建立链脲佐菌素糖尿病大鼠模型。其中20只建模成功,随机均分为不进行治疗的模型组和应用厄贝沙坦治疗的厄贝沙坦组,干预12周。检测... 目的探讨厄贝沙坦对糖尿病肾损伤的治疗作用及其机制。方法取SD大鼠32只,随机选取10只设为正常组,余22只建立链脲佐菌素糖尿病大鼠模型。其中20只建模成功,随机均分为不进行治疗的模型组和应用厄贝沙坦治疗的厄贝沙坦组,干预12周。检测各组肾质量/体质量、血尿素氮(BUN)及尿白蛋白/肌酐(UACR);采用免疫组化法检测大鼠肾组织纤维连接蛋白(FN)、Dickkopf-1(DKK1)及β-连环蛋白(β-catenin)表达(以染色阳性区域面积/整个肾小球面积表示),采用实时荧光定量PCR法检测FN、DKK1、β-catenin mRNA表达。分析糖尿病大鼠肾组织DKK1 mRNA表达与UACR、FN mRNA表达的关系。结果模型组、厄贝沙坦组、正常组肾质量/体质量分别为(4.7±0.6)%、(3.8±0.5)%、(3.2±0.4)%,三组间比较P均<0.05。模型组、厄贝沙坦组血BUN及UACR均高于正常组,厄贝沙坦组均低于模型组(P均<0.05)。模型组、厄贝沙坦肾组织FN、DKK1蛋白表达均高于正常组,β-catenin蛋白表达均低于正常组(P均<0.05);厄贝沙坦组肾组织FN、DKK1蛋白表达均低于模型组,β-catenin蛋白表达均高于模型组(P均<0.05)。模型组、厄贝沙坦组肾组织FN、DKK1 mRNA相对表达量均高于正常组,厄贝沙坦组均低于模型组(P均<0.05);三组肾组织β-catenin mRNA相对表达量比较差异均无统计学意义(P均>0.05)。糖尿病大鼠肾组织DKK1 mRNA表达与UACR、FN mRNA表达均呈正相关(r分别为0.796、0.751,P均<0.05)。结论厄贝沙坦可减缓糖尿病大鼠肾损伤的发生发展,其机制可能为抑制肾组织FN、DKK1表达,促进β-catenin表达。。 展开更多
关键词 糖尿病 糖尿病肾病 厄贝沙坦 纤维连接蛋白 DICKKOPF-1 Β-连环蛋白 大鼠
下载PDF
Hereditary hemochromatosis:Temporal trends,sociodemographic characteristics,and independent risk factor of hepatocellular cancer–nationwide population-based study 被引量:1
3
作者 Maryam Bilal Haider Ali Al Sbihi +2 位作者 Ahmed Jamal Chaudhary Syed M Haider Ahmed Iqbal Edhi 《World Journal of Hepatology》 2022年第9期1804-1816,共13页
BACKGROUND Hereditary hemochromatosis(HH)has an increased risk of hepatocellular cancer(HCC)both due to genetic risks and iron overload as iron overload can be carcinogenic;HH impacts the increasing risk of HCC,not on... BACKGROUND Hereditary hemochromatosis(HH)has an increased risk of hepatocellular cancer(HCC)both due to genetic risks and iron overload as iron overload can be carcinogenic;HH impacts the increasing risk of HCC,not only through the development of cirrhosis but concerning hepatic iron deposition,which has been studied further recently.AIM To evaluate HH yearly trends,patient demographics,symptoms,comorbidities,and hospital outcomes.The secondary aim sheds light on the risk of iron overload for developing HCC in HH patients,independent of liver cirrhosis complications.The study investigated HH(without cirrhosis)as an independent risk factor for HCC.METHODS We analyzed data from National Inpatient Sample(NIS)Database,the largest national inpatient data collection in the United States,and selected HH and HCC cohorts.HH was first defined in 2011 International Classification of Disease-9th edition(ICD-9)as a separate diagnosis;the HH cohort is extracted from January 2011 to December 2019 using 275.01(ICD-9)and E83.110(ICD-10)diagnosis codes of HH.Patients were excluded from the HH cohort if they had a primary or secondary diagnostic code of cirrhosis(alcoholic,non-alcoholic,and biliary),viralhepatitis,alcoholic liver disease,non-alcoholic fatty liver disease(NAFLD),and non-alcoholic steatohepatitis(NASH).We removed these patients from the HH cohort to rule out bias or ICD-10 diagnostic errors.The HCC cohort is selected from January 2011 to December 2019 using the ICD-9 and ICD-10 codes of HCC.We selected a non-HCC cohort with the 1:1 fixed ratio nearest neighbor(greedy)propensity score method using the patients'age,gender,and race.We performed multivariate analysis for the risk factors of HCC in the HCC and non-HCC matched cohort.We further analyzed HH without cirrhosis(removing HH patients with a diagnosis of cirrhosis)as an independent risk factor of HCC after adjusting all known risk factors of HCC in the multivariate model.RESULTS During the 2011-2019 period,a total of 18031 hospitalizations with a primary or secondary diagnosis of HH(excluding liver diseases)were recorded in the NIS database.We analyzed different patients’characteristics,and we found increments in inpatient population trend with a Ptrend<0.001 and total hospital cost of care trend from$42957 in 2011 to$66152 in 2019 with a Ptrend<0.001 despite no change in Length of Stay over the last decade.The multivariate analyses showed that HH without cirrhosis(aOR,28.8;95%CI,10.4–80.1;P<0.0001),biliary cirrhosis(aOR,19.3;95%CI,13.4–27.6;P<0.0001),non-alcoholic cirrhosis(aOR,17.4;95%CI,16.5–18.4;P<0.0001),alcoholic cirrhosis(aOR,16.9;95%CI,15.9–17.9;P<0.0001),hepatitis B(aOR,12.1;95%CI,10.85–13.60;P<0.0001),hepatitis C(aOR,8.58;95%CI,8.20–8.98;P<0.0001),Wilson disease(aOR,4.27;95%CI,1.18–15.41;P<0.0001),NAFLD or NASH(aOR,2.96;95%CI,2.73–3.20;P<0.0001),alpha1-antitrypsin deficiency(aOR,2.10;95%CI,1.21–3.64;P<0.0001),diabetes mellitus without chronic complications(aOR,1.17;95%CI,1.13–1.21;P<0.0001),and blood transfusion(aOR,1.80;95%CI,1.69–1.92;P<0.0001)are independent risk factor for liver cancer.CONCLUSION Our study showed an increasing trend of in-hospital admissions of HH patients in the last decade.These trends were likely related to advances in diagnostic approach,which can lead to increased hospital utilization and cost increments.Still,the length of stay remained the same,likely due to a big part of management being done in outpatient settings.Another vital part of our study is the significant result that HH without cirrhosis is an independent risk factor for HCC with adjusting all known risk factors.More prospective and retrospective large studies are needed to re-evaluate the HH independent risk in developing HCC. 展开更多
关键词 Hereditary hemochromatosis Hepatocellular carcinoma cirrhosis Hepatitis diabetes mellitus Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Wilson disease Alpha1-antitrypsin deficiency Blood transfusion Epidemiology Demographics Big data HOSPITALIZATION
下载PDF
凝集素样氧化型低密度脂蛋白受体-1下调对糖尿病小鼠肝损伤及Ⅲ型纤维连接蛋白域蛋白5的影响研究
4
作者 赵文淑 刘静 +8 位作者 田利民 余静 仇菊梅 张延燕 张雅娟 刘亚倩 张志秀 汪霞 张琦 《中华糖尿病杂志》 CAS CSCD 北大核心 2022年第12期1445-1452,共8页
目的探讨凝集素样氧化型低密度脂蛋白受体-1(LOX-1)下调对糖尿病小鼠肝损伤及Ⅲ型纤维连接蛋白域蛋白5(FNDC5)的影响。方法30只7~8周龄的雄性db/db小鼠进行糖尿病造模,按照随机数字表法将其分为3组:db/db LOX-1敲减[AAV(腺相关病毒)-shL... 目的探讨凝集素样氧化型低密度脂蛋白受体-1(LOX-1)下调对糖尿病小鼠肝损伤及Ⅲ型纤维连接蛋白域蛋白5(FNDC5)的影响。方法30只7~8周龄的雄性db/db小鼠进行糖尿病造模,按照随机数字表法将其分为3组:db/db LOX-1敲减[AAV(腺相关病毒)-shLOX-1]组、db/db空载体(AAV-shCON)组和空白对照(db/db)组,每组10只;10只同龄的雄性db/m小鼠为正常对照(NC)组。采用HE染色观察小鼠肝脏的病理形态,实时荧光定量PCR(qRT-PCR)、Western blotting法检测小鼠肝脏中LOX-1、白细胞介素-6(IL-6)及FNDC5的mRNA和蛋白表达水平,酶联免疫吸附测定(ELISA)法检测血清丙氨酸转氨酶(ALT)、甘油三酯(TG)及FNDC5的水平。采用单因素方差分析进行组间比较。结果HE染色显示,与NC组相比,AAV-shLOX-1组、AAV-shCON组和db/db组小鼠肝小叶结构紊乱,肝细胞内可见大量的空泡样脂滴,呈显著的脂肪变性;与AAV-shCON组和db/db组相比,AAV-shLOX-1组小鼠肝细胞中脂滴数量明显减少,脂肪变性明显减轻。qRT-PCR和Western blotting结果显示,与NC组相比,AAV-shLOX-1组、AAV-shCON组和db/db组小鼠肝脏中LOX-1、IL-6的mRNA和蛋白表达均升高,FNDC5的mRNA和蛋白表达均降低;与AAV-shLOX-1组相比,AAV-shCON组和db/db组小鼠肝脏中LOX-1、IL-6的mRNA和蛋白表达均升高,FNDC5的mRNA和蛋白表达均降低,差异均有统计学意义(P<0.05)。与NC组相比,AAV-shLOX-1组、AAV-shCON组和db/db组小鼠血清中ALT、TG均升高,FNDC5降低;与AAV-shLOX-1组相比,AAV-shCON组和db/db组小鼠血清中ALT、TG均升高,FNDC5均降低,差异均有统计学意义(P<0.05)。结论LOX-1参与调控了db/db小鼠肝损伤和FNDC5的变化,LOX-1下调可减轻db/db小鼠肝脏的脂肪变性及炎症反应,提高db/db小鼠FNDC5的组织和血清水平,糖尿病小鼠的肝损伤可能与LOX-1/FNDC5的调控有关。 展开更多
关键词 糖尿病 非酒精性脂肪性肝病 凝集素样氧化型低密度脂蛋白受体⁃1 Ⅲ型纤维连接蛋白域蛋白5
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部